Organogenesis Holdings (ORGO) Cash from Operations (2016 - 2026)

Organogenesis Holdings' Cash from Operations history runs 11 years deep, the most recent figure standing at 21127000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 205.98% year-over-year to 21127000.0; the TTM figure through Mar 2026 stood at 30753000.0 (up 593.42% YoY), while the FY2025 annual figure was 10309000.0, down 172.56% from the prior year.
• Cash from Operations was 21127000.0 for Q1 2026 at Organogenesis Holdings, down from 39420000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 39420000.0 in Q4 2025 to a low of 32873000.0 in Q2 2025.
• Historically, Cash from Operations has averaged 4753058.82 across 5 years, with a median of 7800000.0 in 2022.
• Biggest YoY gain for Cash from Operations was 260.43% in 2025; the steepest drop was 793.82% in 2025.
• A 5-year view of Cash from Operations shows it stood at 7800000.0 in 2022, then jumped by 36.08% to 10614000.0 in 2023, then climbed by 3.04% to 10937000.0 in 2024, then surged by 260.43% to 39420000.0 in 2025, then sank by 46.41% to 21127000.0 in 2026.
• The last three Cash from Operations figures came in at 21127000.0 (Q1 2026), 39420000.0 (Q4 2025), and 3079000.0 (Q3 2025), per Business Quant data.